May 23, 2024 — HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study, highlighting the accuracy of its Plaque Analysis, was 

May 23, 2024 — Global Heart Hub, the international alliance of heart patient organizations, announced the first findings from their patient-led Insights from Patients living with Elevated Cholesterol (IPEC) data generation program.

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical Center, The University of Texas at Tyler and University of Alabama at Birmingham, shows that exercising, even at very high levels, is not related to the progression of coronary artery calcium (CAC), a marker of atherosclerotic cardiovascular disease.

May 22, 2024 — Voiant (USA) and Thirona (The Netherlands) announced they have entered a global commercial partnership, combining Voiant's expertise in supporting clinical trials in pulmonary drug and treatment development with Thirona's expertise in advanced lung im

May 23, 2024 — A newly-published peer-reviewed study in the Journal of the American Heart Association, JAHA, found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.

May 21, 2024 — Anumana, a Cambridge, MA-based artificial intelligence (AI)-driven health technology company and portfolio company of nference, has announced it has received the International Organization for Standardization (ISO) 13485 certification for its Quality Management System. 

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has

May 21, 2024 — A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 8, entitled, “Associations among NMR-measured inflammatory and metabolic biomarkers and accelerated aging in cardiac catheterization patients.”

May 20, 2024 — Ochsner Medical Center - Baton Rouge has earned The Joint Commission’s Gold Seal of Approval and the American Stroke Association’s Heart-Check mark for Acute Stroke Ready Certification. 

The designation means OMC-Baton Rouge meets The Joint Commission's designation for readiness to treat patients who experience severe stroke.  

May 20, 2024 — Cardiologist Brendan Carry, MD, and a team of Danville, PA-based Geisinger Medical Center physicians have enrolled the first patient in the U.S. into a cardiac amyloidosis trial. The team is also the first to in the U.S. to screen for the trial.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now